Check-Cap Ltd. (CHEK)

USD 0.67

(-0.95%)

Long Term Debt Summary of Check-Cap Ltd.

  • Check-Cap Ltd.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
  • Check-Cap Ltd.'s latest quarterly long term debt in 2023 FY was - USD , down -100.0% from previous quarter.
  • Check-Cap Ltd. reported annual long term debt of 627 Thousand USD in 2022, down -21.13% from previous year.
  • Check-Cap Ltd. reported annual long term debt of 795 Thousand USD in 2021, up 536.0% from previous year.
  • Check-Cap Ltd. reported quarterly long term debt of - USD for 2023 Q2, down -100.0% from previous quarter.
  • Check-Cap Ltd. reported quarterly long term debt of - USD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Check-Cap Ltd. (2023 - 2012)

Historical Annual Long Term Debt of Check-Cap Ltd. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 - USD -100.0%
2022 627 Thousand USD -21.13%
2021 795 Thousand USD 536.0%
2020 125 Thousand USD -40.76%
2019 211 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of Check-Cap Ltd.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 100.0%
Applied DNA Sciences, Inc. 739.16 Thousand USD 100.0%
Aspira Women's Health Inc. 1.43 Million USD 100.0%
Biodesix, Inc. 35.22 Million USD 100.0%
BioNexus Gene Lab Corp. 98.76 Thousand USD 100.0%
bioAffinity Technologies, Inc. 1.11 Million USD 100.0%
bioAffinity Technologies, Inc. 1.11 Million USD 100.0%
Bionano Genomics, Inc. 7.17 Million USD 100.0%
CareDx, Inc 28.27 Million USD 100.0%
Castle Biosciences, Inc. 14.19 Million USD 100.0%
DarioHealth Corp. 24.59 Million USD 100.0%
Exact Sciences Corporation 2.47 Billion USD 100.0%
Fulgent Genetics, Inc. 10.11 Million USD 100.0%
Guardant Health, Inc. 1.13 Billion USD 100.0%
ICON Public Limited Company 3.66 Billion USD 100.0%
IDEXX Laboratories, Inc. 622.88 Million USD 100.0%
Illumina, Inc. 1.48 Billion USD 100.0%
Intelligent Bio Solutions Inc. 81.32 Thousand USD 100.0%
iSpecimen Inc. 29.13 Thousand USD 100.0%
Standard BioTools Inc. 3.98 Million USD 100.0%
MDxHealth SA 35.56 Million USD 100.0%
23andMe Holding Co. 67.84 Million USD 100.0%
Medpace Holdings, Inc. 142.12 Million USD 100.0%
Myriad Genetics, Inc. 130.9 Million USD 100.0%
Mainz Biomed B.V. 2.19 Million USD 100.0%
ENDRA Life Sciences Inc. 192.06 Thousand USD 100.0%
NeoGenomics, Inc. 606.06 Million USD 100.0%
Neogen Corporation 888.39 Million USD 100.0%
Inotiv, Inc. 399.4 Million USD 100.0%
Natera, Inc. 282.94 Million USD 100.0%
OpGen, Inc. 2.02 Million USD 100.0%
OPKO Health, Inc. 222.03 Million USD 100.0%
Psychemedics Corporation 945 Thousand USD 100.0%
Prenetics Global Limited 867.21 Thousand USD 100.0%
Prenetics Global Limited 867.21 Thousand USD 100.0%
Precipio, Inc. 106 Thousand USD 100.0%
Personalis, Inc. 1.23 Million USD 100.0%
RadNet, Inc. 812.06 Million USD 100.0%
Sera Prognostics, Inc. 840 Thousand USD 100.0%
Sotera Health Company 2.22 Billion USD 100.0%
Neuronetics, Inc. 59.28 Million USD 100.0%
Star Equity Holdings, Inc. 1.14 Million USD 100.0%
Star Equity Holdings, Inc. 1.14 Million USD 100.0%
Trinity Biotech plc 54.65 Million USD 100.0%
T2 Biosystems, Inc. 6.59 Million USD 100.0%
Twist Bioscience Corporation 79.17 Million USD 100.0%
Exagen Inc. 19.23 Million USD 100.0%